Epidemic obesity and type 2 diabetes in Asia

Lancet

Volumn 368, Issue 9548, 2006, Pages 1681-1688

  Yoon, Kun Ho ^a   Lee, Jin Hee ^a   Kim, Ji Won ^a   Cho, Jae Hyoung ^a   Choi, Yoon Hee ^a   Ko, Seung Hyun ^a   Zimmet, Paul ^b   Son, Ho Young ^a  

^a The Catholic University of Korea   (South Korea)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

ASIA; COST; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EPIDEMIC; GENETIC PREDISPOSITION; HEALTH; HEALTH BEHAVIOR; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW;

EID: 33845984333     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69703-1     Document Type: Review

References (113)

1. King H., Aubert R., and Herman W. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
2. Sicree R., Shaw J., and Zimmet P. The global burden of diabetes. In: Gan D. (Ed). Diabetes Atlas. 2nd edn. (2003), International Diabetes Federation, Brussels 15-71
3. Roglic G., and King H. Diabetes mellitus in Asia. Hong Kong Med J 6 (2000) 10-11
4. Ko G., Chan J., Cockram C., and Woo J. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 23 (1999) 1136-1142
5. He J., Klag M., Whelton P., Chen J., Qian M., and He G. Body mass and blood pressure in a lean population in southwestern China. Am J Epidemiol 139 (1994) 380-389
6. King H., Keuky L., Seng S., Khun T., Roglic G., and Pinget M. Diabetes and associated disorders in Cambodia: two epidemiological surveys. Lancet 366 (2005) 1633-1639
7. Park Y., Allison D., Heymsfield S., and Gallagher D. Larger amounts of visceral adipose tissue in Asian Americans. Obesity Res 9 (2001) 381-387
8. He Q., Horlick M., Thornton J., et al. Sex and race differences in fat distribution among Asian, African-American, and Caucasian prepubertal children. J Clin Endocrinol Metab 87 (2002) 2164-2170
9. Chen K., Boyko E., Bergstrom R., et al. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men. Diabetes Care 18 (1995) 747-753
10. Matsumoto K., Miyake S., Yano M., et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 20 (1997) 1562-1568
11. Fukushima M., Suzuki H., and Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract 66 suppl 1 (2004) 37-43
12. Rattarasarn C., Soonthornpan S., Leelawattana R., and Setasuban W. Decreased insulin secretion but not insulin sensitivity in normal glucose tolerant Thai subjects. Diabetes Care 29 (2006) 742-743
13. Gregg E., Cadwell B., Cheng Y., et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the US. Diabetes Care 27 (2004) 2806-2812
14. King H., and Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 16 (1993) 157-177
15. National Diabetes Co-operative Study Group. A mass survey of diabetes mellitus in a population of 300 000 in 14 provinces and municipalities in China. Chinese J Intern Med 20 (1981) 678-683
16. Xiang H., Liu C., Wu W., et al. An epidemiological study on diabetes mellitus 1995-1996, in China. Chinese J Diabetes 6 (1998) 131-133
17. Qiao Q., Hu G., Tuomilehto J., et al. Age- and Sex-Specific Prevalence of Diabetes and Impaired Glucose Regulation in 11 Asian Cohorts. Diabetes Care 26 6 (2003) 1770-1780
18. Sadikot S., Nigam A., Das S., et al. Comparing the ADA 1997 and the WHO 1999 criteria: Prevalence of Diabetes in India Study. Diabetes Res Clin Pract 66 (2004) 309-315
19. Ramachandran A., Snehalatha C., Baskar A., et al. Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia 47 (2004) 860-865
20. Ramachandran A., Snehalatha C., and Vijay V. Temporal changes in prevalence of type 2 diabetes and impaired glucose tolerance in urban southern India. Diabetes Res Clin Pract 58 (2002) 55-60
21. Ramachandran A., Snehalatha C., Kapur A., et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44 (2001) 1094-1101
22. Patandin S., Bots M., Abel R., and Valkenburg H. Impaired glucose tolerance and diabetes mellitus in a rural population in South India. Diabetes Res Clin Pract 24 (1994) 47-53
23. Kim K., Choi C., Lee D., and Jin K. Epidemiological study on diabetes mellitus among rural Korean. J Kor Diabetes Assoc 1 (1972) 17-24
24. Kim S., Lee J., Lee J., et al. Prevalence of diabetes and impaired fasting glucose in Korea: Korean national health and nutrition survey 2001. Diabetes Care 29 (2006) 226-231
25. Sutanegara D., and Budhiarta A. The epidemiology and management of diabetes mellitus in Indonesia. Diabetes Res Clin Pract 50 suppl 2 (2000) 9-16
26. Khalid B., Usha R., Ng M., Norella Kong C., and Tariq A. Prevalence of diabetes, hypertension and renal disease amongst railway workers in Malaysia. Med J Malaysia 45 (1990) 8-13
27. Aekplakorn W., Stolk R., Neal B., et al. The prevalence and management of diabetes in Thai adults: The international collaborative study of cardiovascular disease in Asia. Diabetes Care 26 (2003) 2758-2763
28. Pan X., Hu Y., Li G., Liu P., Bennett P., and Howard B. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study. Diabetes Care 16 (1993) 150-156
29. Gu D., Reynolds K., Duan X., et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 46 (2003) 1190-1198
30. Chau I., and Khalid B. A survey of diabetes mellitus and its complications in the General Hospital, Kuala Lumpur. J ASEAN Fed Endoc Soc 6 (1987) 74-81
31. Cheah J., Yeo P., Thai A., et al. Epidemiology of diabetes mellitus in Singapore: comparison with other ASEAN countries. Ann Acad Med Singapore 14 (1985) 232-239
32. Tan C., Emmanuel S., Tan B., and Jacob E. Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 22 (1999) 241-247
33. Chang C.-J., Lu F.-H., Yang Y.-C., et al. Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 50 suppl 2 (2000) 49-59
34. Feng-Hwa L., Yang Y.-C., Wu J.-S., Wu C.-H., and Chang C.-J. A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan. Diabet Med 15 (1998) 564-572
35. World Health Organization Study Group. Diabetes Mellitus: Technical Report Series 727 (1985), WHO, Geneva, Switzerland
36. Alberti K., Aschner P., Assal J., et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus (1999), World Health Organization, Geneva
37. Gavin J., Alberti K., Davidson M., et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
38. Segi M. Cancer mortality for selected sites in 24 countries (1950-57) (1960), Tohoku University Press, Sendai, Japan
39. Cockram C. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J 6 (2000) 43-52
40. Cockram C., Woo J., Lau E., et al. The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age. Diabetes Res Clin Pract 21 (1993) 67-73
41. Takahashi Y., Noda M., Tsugane S., Kuzuya T., Ito C., and Kadowaki T. Prevalence of diabetes estimated by plasma glucose criteria combined with standardized measurement of HbA1c among health checkup participants on Miyako Island, Japan. Diabetes Care 23 (2000) 1092-1096
42. Centers for Disease Control and Prevention. Prevalence of diabetes and impaired fasting glucose in adults-United States, 1999-2000. MMWR Morb Mortal Wkly Rep 52 (2003) 833-837
43. Duc Son L., Kusama K., Hung N., et al. Prevalence and risk factors for diabetes in Ho Chi Minh City, Vietnam. Diabet Med 21 (2004) 371-376
44. Sadikot S., Nigam A., Das S., et al. The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract 66 (2004) 301-307
45. Chu N. Prevalence of obesity in Taiwan. Obesity Rev 6 (2005) 271-274
46. Wu Y. Overweight and obesity in China. BMJ 333 (2006) 362-363
47. Alberti G., Zimmet P., Shaw J., Bloomgarden Z., Kaufman F., and Silink M. Type 2 diabetes in the young: the evolving epidemic: the International Diabetes Federation consensus workshop. Diabetes Care 27 (2004) 1798-1811
48. Owada M., and Kitagawa T. Diabetes Screening in School Health System. Chiryo 77 (1995) 3047-3053
49. Kitagawa T., Owada M., Urakami T., et al. Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin Pediatr 37 (1998) 111-115
50. Sung R., Tong P., Yu C.-W., et al. High prevalence of insulin resistance and metabolic syndrome in overweight/obese preadolescent Hong Kong Chinese children aged 9-12 years. Diabetes Care 26 (2003) 250-251
51. United State Renal Data System. 2005 Annual data report; atlas of end-stage renal disease in the United States (2006), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
52. WHO. Preventing chronic disease: a vital investment. WHO global report (2005), World Health Organization, Geneva, Switzerland
53. Flegal K., Carroll M., Ogden C., and Johnson C. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
54. Griffiths P., and Bentley M. The nutrition transition is underway in India. J Nutr 131 (2001) 2692-2700
55. Prentice A. The emerging epidemic of obesity in developing countries. Int J Epidemiol 35 (2006) 93-99
56. Baltazar J., Ancheta C., Aban I., Fernando R., and Baquilod M. Prevalence and correlates of diabetes mellitus and impaired glucose tolerance among adults in Luzon, Philippines. Diabetes Res Clin Pract 64 (2004) 107-115
57. Lin Y.-C., Yen L.-L., Chen S.-Y., et al. Prevalence of overweight and obesity and its associated factors: findings from National Nutrition and Health Survey in Taiwan, 1993-1996. Prev Med 37 (2003) 233-241
58. Ko G., Wu M., Tang J., Wai H., Chan C., and Chen R. Body mass index profile in Hong Kong Chinese adults. Ann Acad Med Singapore 30 (2001) 393-396
59. Janus E., Wat N., Lam K., et al. The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Diabet Med 17 (2000) 741-745
60. Deurenberg-Yap M., Chew S., Lin V., Tan B., van Staveren W., and Deurenberg P. Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore. Int J Obes 25 (2001) 1554-1562
61. Kim D., Ahn C., and Nam S. Prevalence of obesity in Korea. Obesity Rev 6 (2005) 117-121
62. Aekplakorn W., Chaiyapong Y., Neal B., et al. Prevalence and determinants of overweight and obesity in Thai adults: results of the second national health examination survey. J Med Assoc Thai 87 (2004) 685-693
63. Ge K. Body mass index of young Chinese adults. Asia Pac J Clin Nutr 6 (1997) 175-179
64. Ko G., Chan J., Woo J., et al. Simple anthropometric indexes and cardiovascular risk factors in Chinese. Int J Obes Relat Metab Disord 21 (1997) 995-1001
65. Yoshiike N., Matsumura Y., Zaman M., and Yamaguchi M. Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990-1994. Int J Obes Relat Metab Disord 22 (1998) 684-687
66. Oh S., Shin S.-A., Yun Y., Yoo T., and Huh B.-Y. Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obesity Res 12 (2004) 2031-2040
67. Shin C., Lee H., Koh C., et al. Risk factors for the development of NIDDM in Yonchon County, Korea. Diabetes Care 20 (1997) 1842-1846
68. Yusuf S. Obesity and risk of myocardial infarction: the INTERHEART study-Author's reply. Lancet 367 (2006) 1054
69. Dong Y., Gao W., Nan H., et al. Prevalence of Type 2 diabetes in urban and rural Chinese populations in Qingdao, China. Diabet Med 22 (2005) 1427-1433
70. Ramachandran A., Snehalatha C., Dharmaraj D., and Viswanathan M. Prevalence of glucose intolerance in Asian Indians. Urban-rural difference and significance of upper body adiposity. Diabetes Care 15 (1992) 1348-1355
71. Ramachandran A., Snehalatha C., Latha E., Vijay V., and Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia 40 (1997) 232-237
72. Korean Ministry of Health and Welfare. Korean national health and nutrition survey (2002), Ministry of Health and Welfare, Republic of Korea
73. WHO. Diet, nutrition and the prevention of chronic diseases (2003), World Health Organization, Geneva, Switzerland
74. Prentice A., and Jebb S. Obesity in Britain: gluttony or sloth?. BMJ 311 (1995) 437-439
75. Hodge A., Dowse G., and Zimmet P. Diet does not predict incidence or prevalence of non-insulin-dependent diabetes in Nauruans. Asia Pac J Clin Nutr 2 (1993) 35-42
76. Popkin B. The nutrition transition and its health implications in lower-income countries. Public Health Nutr 1 (1998) 5-21
77. Drewnowski A., and BM P. The nutrition transition: new trends in the global diet. Nutr Rev 55 (1997) 31-43
78. Popkin B. Nutritional patterns and transitions. Popul Dev Rev 19 (1993) 138-157
79. Popkin B., Keyou G., Zhai F., Guo X., Ma H., and Zohoori N. The nutrition transition in China: a cross-sectional analysis. Eur J Clin Nutr 47 (1993) 333-346
80. Popkin B. The nutrition transition in low-income countries: an emerging crisis. Nutr Rev 52 (1994) 285-298
81. Popkin B., Horton S., Kim S., Mahal A., and Shuigao J. Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. Nutr Rev 59 (2001) 379-390
82. Du S., Lu B., Zhai F., and Popkin B. A new stage of the nutrition transition in China. Public Health Nutr 5 (2002) 169-174
83. Popkin B., and Du S. Dynamics of the nutrition transition toward the animal foods sector in China and its implications: a worried perspective. J Nutr 133 suppl 2 (2003) 3898-3906
84. Popkin B., and Doak C. The obesity epidemic is a worldwide phenomenon. Nutr Rev 56 (1998) 106-114
85. World Bank. World development indicators 1998. Socioeconomic Time Series Access and Retrieval System. Version 4.01. [CD-ROM] (1998), World Bank, Washington, DC
86. Kim S., Moon S., and Popkin B. The nutrition transition in South Korea. Am J Clin Nutr 71 (2000) 44-53
87. Yoshiike N., Matsumura Y., Iwaya M., Sugiyama M., and Yamaguchi M. National nutrition survey in Japan. J Epidemiol 6 suppl 3 (1996) 189-200
88. Bar-Or O., Foreyt J., Bouchard C., et al. Physical activity, genetic, and nutritional considerations in childhood weight management. Med Sci Sports Exerc 30 (1998) 2-10
89. Wang J., Thornton J., Burastero S., et al. Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York City area. Obesity Res 4 (1996) 377-384
90. He M., Kung A., and Li E. The validity of BMI as an obesity criterion in Chinese adults. HK Pract 20 suppl 2 (1998) 6
91. Araneta M., Wingard D., and Barrett-Connor E. Type 2 diabetes and metabolic syndrome in Filipina-American women : A high-risk nonobese population. Diabetes Care 25 (2002) 494-499
92. Yajnik C., and Yudkin J. The Y-Y paradox. Lancet 363 (2004) 163
93. Deurenberg-Yap M., Li T., Tan W., and van Staveren W. P. D. Validation of a semiquantitative food frequency questionnaire for estimation of intakes of energy, fats and cholesterol among Singaporeans. Asia Pac J Clin Nutr 9 (2000) 282-288
94. Tam T., Gross R., Lukito W., and Rumawas J. Chronic energy deficiency and relative abdominal overfatness coexist in free-living elderly individuals in Ho Chi Minh City, Vietnam. Asia Pac J Clin Nutr 8 (1999) 129-135
95. World Health Organization, and International Obesity Task Force. The Asian-Pacific perspective: redefining obesity and its treatment (2000), WHO Western Pacific Region, Geneva, Switzerland
96. Zimmet P. Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted?. J Intern Med 247 (2000) 301-310
97. Yoon K., Ko S., Cho J., et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88 (2003) 2300-2308
98. Butler A., Janson J., Bonner-Weir S., Ritzel R., Rizza R., and Butler P. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003) 102-110
99. Sakuraba H., Mizukami H., Yagihashi N., Wada R., Hanyu C., and Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 45 (2002) 85-96
100. Gepts W., and Lecompte P. The pancreatic islets in diabetes. Am J Med 70 (1981) 105-115
101. Ken S., Nobuhisa Y., and Takahashi T. Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J Exp Med 129 (1979) 273-283
102. Kloppel G., Lohr M., Habich K., Oberholzer M., and Heitz P. Islet pathology and pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Path Res 4 (1985) 110-125
103. Clark A., Wells C., Buley I., et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9 (1988) 151-159
104. Stefan Y., Orci L., Malaisse-Lagae F., Perrelet A., Patel Y., and Unger R. Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 31 (1982) 694-700
105. Ko S., Hong O., Kim J., et al. High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem 98 (2006) 343-355
106. Ko S.-H., Kwon H.-S., Kim S.-R., et al. Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commun 316 (2004) 114-122
107. Cooper M., Tikellis C., and Thomas M. Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system. J Hypertens 24 suppl 1 (2006) 57 53
108. Derek Y., David S., and Brownell K. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nature Med 12 (2006) 62-66
109. Knowler W., Barrett-Connor E., Fowler S., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
110. Pan X., Li G., Hu Y., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20 (1997) 537-544
111. Tuomilehto J., Lindstrom J., Eriksson J., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
112. Kosaka K., Noda M., and Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 67 (2005) 152-162
113. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A., and Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49 (2006) 289-297